166
Participants
Start Date
September 1, 2018
Primary Completion Date
April 1, 2022
Study Completion Date
April 1, 2022
HRHA
participants will be asked to consider a hypothetical scenario in which genetic test results reveal that: 1) they carry genotypes that place African American smokers at a particularly high (\~50%-80%) risk for the development of lung cancer, and 2) their genetic profile reflects a particularly high concordance with African heritage (\~90%).
LRLA
participants will be asked to consider a scenario in which genetic test results reveal that: 1) they are at normal (\~7%-10%) risk for the development of lung cancer, and 2) their genetic profile reflects a particularly low concordance with African heritage (\~10%).
HRLA
"participants will receive High Risk, Low Ancestry (HRLA) hypothetical"
LRHA
"participants will receive Low Risk, High Ancestry (HRLA) hypothetical"
Hunter College, New York
Fox Chase Cancer Center, Philadelphia
National Cancer Institute (NCI)
NIH
Temple University
OTHER